MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Significant pathways detected. by Chiara Balestra (14769091)

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

UK Biobank analysis: Numbers of significant independent associations detected. by Corbin Quick (9363574)

“…<p>Numbers of independent gene-based associations (at Bonferroni-corrected 5% significance level) detected by each method across 128 UK Biobank traits. …”

KEGG enrichment pathway based on the significant metabolites detected in RSA and control group. by AiNing Wu (17692252)

“…<p>KEGG enrichment pathway based on the significant metabolites detected in RSA and control group.…”

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Distribution of variants of uncertain significance (VUS) detected in 125 probands. by Samuel Guan Wei Ow (3204204)

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

SDI-based age-standardized rates of DALYs and ASDR for IHD attributable to HSBP. by Zhenhua Zhuang (11192745)

Subjects:

Significance of weight. by Nurul Hidayah Watimin (17200317)